Acute acneiform eruption secondary to MK-672.
D000152:Acne Vulgaris / Q000382:microbiology; D000818:Animals; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001706:Biopsy; D002986:Clinical Trials as Topic; D003352:Corynebacterium / Q000302:isolation & purification; D003875:Drug Eruptions / Q000209:etiology* / Q000382:microbiology; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D010919:Placebos; D011719:Pyrazines / Q000009:adverse effects*; D012867:Skin / Q000382:microbiology
D000959:Antihypertensive Agents; D007093:Imidazoles; D010919:Placebos; D011719:Pyrazines